20.04.2013 Views

S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS

S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS

S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

450<br />

Leitlinie<br />

The methodologic recommendations of the AWMF on the preparation<br />

of guidelines (http://www.awmf-leitlinien.de), the<br />

guideline manual of the Medical Center of Quality in Medicine<br />

(http://www.aezq.de), and the German Instrument on Methodologic<br />

<strong>Guideline</strong> Evaluation (http://www.delbi.de) were the<br />

basis for the organization of the guideline procedure. As is demonstrated<br />

in the following chapter (guideline report), the<br />

guideline fulfills the criteria of an evidence and consensusbased<br />

guideline (<strong>S3</strong>).<br />

This guideline is estimated to be valid for 3 years. If during this<br />

time important changes in care become evident, the coordination<br />

groups will decide whether individual topics or the complete<br />

guideline must be updated ahead of time.<br />

The preparation of the guideline was financially supported by<br />

the <strong>DGVS</strong> and the DKG. The work of the participants taking<br />

part in the consensus process and the resulting recommendations<br />

were not influenced by this support.<br />

This manuscript is the English version of the German guidelines<br />

that were published in the Zeitschrift für Gastroenetrologie<br />

in June 2007 [1].<br />

Organizational procedure and methodologic basis of<br />

the consensus process (guideline report)<br />

!<br />

Following the commission by the <strong>DGVS</strong> and the DKG, the organizational<br />

procedure for the guideline preparation was discussed<br />

with the chairman of the guideline commission, Prof. H.-K.<br />

Selbmann. Subsequent methodologic supervision was done by<br />

the vice chairman Dr. Ina Kopp. The guideline project was registered<br />

at the AWMF on July 4, 2005 (AWMF-Register-No. 032/<br />

010).<br />

Recruitment of participants<br />

To recruit the members of the steering committee (coordinators)<br />

presidents of the societies involved in diagnostics, therapy,<br />

and follow-up of pancreatic carcinoma were asked to<br />

name two representatives. After voting on the topics, the naming<br />

and invitation of task force members was performed together<br />

with the coordinators (l " Table 1). Participants were doctors<br />

from various care levels who work in hospitals and private<br />

practices. They represented the key disciplines that are relevant<br />

for pancreatic carcinoma: internal medicine (gastroenterology,<br />

hematology-oncology), surgery (visceral surgery), radiooncology,<br />

pathology, diagnostic radiology, palliative medicine,<br />

pain therapy, dietary medicine, psychotherapy-psychosomatics,<br />

laboratory medicine, and epidemiology. The patients’ representative<br />

was appointed by the Task Force of the Pancreatectomized<br />

Patients e. V. Dormagen.<br />

Organizational procedure<br />

Following the voting on the topics with the coordinators, the<br />

list of questions was generated and the search terms for the<br />

literature search were defined (time course l " Table 2). Afterwards<br />

the list of questions and the search terms were revised<br />

and amended by the task forces. A systematic literature<br />

search according to defined search terms was done in<br />

PubMed/Medline for the period from 1995 to May 2006 (inclusive).<br />

The search terms that were used are listed in the<br />

appendix. A total of 42345 citations were viewed (l " Table 3)<br />

and appendix (l " Table 10). 1409 were chosen according to<br />

the following criteria: investigations in humans, original arti-<br />

Adler G et al. <strong>S3</strong>-<strong>Guideline</strong> <strong>“Exocrine</strong> <strong>Pancreatic</strong>… Z Gastroenterol 2008; 46: 449–482<br />

Table 1 Task forces<br />

1. Risk factors/screening/risk groups<br />

chairmen<br />

S.C. Bischoff Universität Hohenheim, Lehrstuhl für Ernährungsmedizin<br />

und Prävention, Stuttgart<br />

S. Hahn Knappschaftskrankenhaus, Medizinische Universitätsklinik,<br />

Bochum<br />

R. Schmid Klinikum rechts der Isar der TU, II. Medizinische<br />

Klinik und Poliklinik, München<br />

members<br />

G. Adler Universitätsklinikum, Zentrum für Innere Medizin,<br />

Klinik für Innere Medizin I, Ulm<br />

A. Aschoff Universitätsklinikum, Klinik für Diagnostische und<br />

Interventionelle Radiologie, Ulm<br />

I. Bergheim Universität Hohenheim, Lehrstuhl für Ernährungsmedizin<br />

und Prävention, Stuttgart<br />

T. Gress Universitätsklinikum Giessen und Marburg GmbH,<br />

Klinik für Innere Medizin, SP Gastroenterologie,<br />

Endokrinologie und Stoffwechsel, Marburg<br />

V. Keim Universitätsklinikum, Medizinische Klinik und Poliklinik<br />

II, Leipzig<br />

M. Lerch Universitätsklinikum, Klinik und Poliklinik für Innere<br />

Medizin A, Greifswald<br />

J. Lüttges Klinikum Saarbrücken, Pathologisches Institut,<br />

Saarbrücken<br />

G. Nagel Universität Ulm, Institut für Epidemiologie, Ulm<br />

H. Rieder Universitätsklinikum, Institut für Humangenetik<br />

und Anthropologie, Düsseldorf<br />

2. Diagnostics<br />

chairmen<br />

H.-J. Brambs Universitätsklinikum, Klinik für Diagnostische und<br />

Interventionelle Radiologie, Ulm<br />

K. Schlottmann Katharinen-Hospital gGmbH, Innere Klinik I, Unna<br />

B. Wiedenmann CharitØ Universitätsmedizin, CharitØCentrum 13,<br />

Medizinische Klinik mit SP Hepatologie und Gastroenterologie,<br />

Campus Virchow, Berlin<br />

members<br />

M. Dobritz Klinikum rechts der Isar der TU, Institut für Rçntgendiagnostik,<br />

München<br />

P. Mçller Universitätsklinikum, Comprehensive Cancer<br />

Center, Institut für Pathologie, Ulm<br />

J. Mçssner Universitätsklinikum, Zentrum für Innere Medizin,<br />

Medizinische Klinik und Poliklinik II; Gastroenterologie<br />

und Hepatologie, Leipzig<br />

S.T. Post Universitätsklinikum gGmbH, Chirurgische Klinik,<br />

Mannheim<br />

S.N. Reske Universitätsklinikum, Klinik für Nuklearmedizin,<br />

Ulm<br />

J.F.Riemann Klinikum der Stadt Ludwigshafen am Rhein<br />

gGmbH, Medizinische Klinik C, Ludwigshafen<br />

T. Rçsch CharitØ Universitätsmedizin, CharitØCentrum 13,<br />

Medizinische Klinik mit SP Hepatologie und Gastroenterologie,<br />

Zentrale interdisziplinäre Endoskopie,<br />

Campus Virchow, Berlin<br />

A.-O. Schäfer Universitätsklinikum, Radiologische Universitätsklinik,<br />

Rçntgendiagnostik, Freiburg<br />

W. Uhl St. Josef-Hospital, Klinikum der Ruhr-Universität,<br />

Klinik für Chirurgie, Bochum<br />

C. Wagener Universitätsklinikum, Institut für Klinische Chemie/Zentrallaboratorien,<br />

Hamburg-Eppendorf<br />

3. Surgical therapy of pancreatic carcinoma (curative intention)<br />

chairmen<br />

J. Werner Universitätsklinikum, Chirurgische Klinik, Klinik<br />

für Allgemein-, Viszeral- und Transplantationschirurgie,<br />

Heidelberg<br />

W. Hohenberger Chirurgische Klinik mit Poliklinik der Friedrich-<br />

Alexander-Universität Erlangen-Nürnberg, Allgemeine,<br />

Bauch- und Thoraxchirurgie, Erlangen<br />

Downloaded by: Thieme Verlagsgruppe. Copyrighted material.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!